Patient disposition and characteristics
Movement Disorder, Parkinson’s Disease Rating Scale
MOVEMENT DISORDER
From March 2021 to December 2021, 61 patients were enrolled, and 11 dropped out during the observation period. The remaining 50 patients were randomly assigned to the zonisamide add-on group (Patient disposition. MDS-UPDRS, The Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale; mITT, modified intention-to-treat; PP, per protocol.
Patient characteristics at baseline (mITT population)Data are 